Drawing for MESSENGER MEDICINES

USPTO serial 90234250

MESSENGER MEDICINES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RINKER, ANTHONY MICHAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MESSENGER MEDICINES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron Y. Silverstein

Aaron Y. Silverstein Saunders & Silverstein LLP14 Cedar Street, Suite 224Amesbury, MA 01913United States

Goods and services

ClassDescriptionStatusFirst use
001chemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processesACTIVE—
005a full line of pharmaceuticals and medicines; therapeutic agents, namely, nucleic acid sequences for medical purposesACTIVE—
042scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeuticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 8, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 8, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 30, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 30, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 30, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 30, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 10, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 10, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 10, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 10, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 6, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 2, 2023EX4GSOU EXTENSION 4 GRANTED—
Jun 2, 2023EXT4SOU EXTENSION 4 FILED—
Jun 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 6, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 2, 2022EX3GSOU EXTENSION 3 GRANTED—
Dec 2, 2022EXT3SOU EXTENSION 3 FILED—
Dec 2, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 10, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 7, 2022EX2GSOU EXTENSION 2 GRANTED—
May 7, 2022EXT2SOU EXTENSION 2 FILED—
May 7, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 3, 2021EX1GSOU EXTENSION 1 GRANTED—
Dec 3, 2021EXT1SOU EXTENSION 1 FILED—
Dec 3, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 8, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 13, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 13, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 24, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 5, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 5, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 5, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 5, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 1, 2021DOCKASSIGNED TO EXAMINER—
Nov 18, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 7, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance